Synthesis, characterization, and cytotoxicity of doxorubicin-loaded polycaprolactone nanocapsules as controlled anti-hepatocellular carcinoma drug release system
Bibliographic Information Authors: Fahmi A.; Abdur-Rahman M.; Mahareek O.; shemis M.A. Journal: BMC Chemistry Publisher: BioMed Central Ltd Publication Date: 12 November 2022 Volume / Issue: Volume 16 / Issue 1 Article No.: 95 ISSN: 2661801X DOI: 10.1186/s13065-022-00888-w Scopus: View on Scopus Document Type: Article Access: All Open Access; Gold Open Access; Green Open Access Authors and Affiliations Fahmi A., Chemistry Department, Faculty of Science, Cairo University, Giza, 12613, Egypt; Abdur-Rahman M., Chemistry Department, Faculty of Science, Cairo University, Giza, 12613, Egypt; Mahareek O., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, 12411, Egypt; shemis M.A., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, 12411, Egypt Abstract Background: Free doxorubicin (Dox) is used as a chemotherapeutic agent against hepatocellular carcinoma (HCC), but it results in cardioto...